CWC
ARKG icon

Carolinas Wealth Consulting’s ARK Genomic Revolution ETF ARKG Stock Holding History

Carolinas Wealth Consulting’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-568
Closed -$11.8K – 60
2025
Q1 		$11.8K Hold
568
– – ﹤0.01% 509
2024
Q4 		$13.4K Sell
568
-1,062
-65% -$26.1K ﹤0.01% 517
2024
Q3 		$41.7K Sell
1,630
-529
-25% -$13.5K 0.01% 389
2024
Q2 		$50.7K Sell
2,159
-378
-15% -$9.54K 0.01% 361
2024
Q1 		$73K Sell
2,537
-759
-23% -$22.8K 0.01% 320
2023
Q4 		$108K Sell
3,296
-1,241
-27% -$33.7K 0.02% 222
2023
Q3 		$104K Sell
4,537
-1,040
-19% -$34K 0.03% 212
2023
Q2 		$190K Hold
5,577
– – 0.04% 176
2023
Q1 		$168K Sell
5,577
-298
-5% -$9.23K 0.04% 189
2022
Q4 		$166K Sell
5,875
-1,620
-22% -$51.4K 0.04% 185
2022
Q3 		$246K Sell
7,495
-535
-7% -$19.6K 0.06% 133
2022
Q2 		$253K Sell
8,030
-926
-10% -$32.4K 0.06% 133
2022
Q1 		$411K Sell
8,956
-2,252
-20% -$107K 0.09% 101
2021
Q4 		$689K Sell
11,208
-390
-3% -$27K 0.15% 76
2021
Q3 		$867K Sell
11,598
-407
-3% -$34.1K 0.2% 57
2021
Q2 		$1.11M Sell
12,005
-848
-7% -$72.1K 0.24% 50
2021
Q1 		$1.14M Sell
12,853
-777
-6% -$77.1K 0.28% 47
2020
Q4 		$1.27M Buy
13,630
+563
+4% +$44.9K 0.34% 40
2020
Q3 		$833K Sell
13,067
-204
-2% -$12K 0.28% 48
2020
Q2 		$692K Buy
13,271
+4,256
+47% +$183K 0.27% 48
2020
Q1 		$282K Buy
+9,015
New +$301K 0.15% 74

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Carolinas Wealth Consulting's ARKG Position: Q2 2025 in Review

Carolinas Wealth Consulting sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2025, closing a stake of 568 shares — an estimated $11.8K sold.

Carolinas Wealth Consulting first reported a position in ARKG in Q1 2020 and held it in 21 quarters. The position peaked at $1.27M in Q4 2020. 213 funds tracked by Wall St. Rank hold ARKG as of Q2 2025.

  • Carolinas Wealth Consulting reported no remaining ARK Genomic Revolution ETF position as of Q2 2025 after selling out during the quarter.
  • Carolinas Wealth Consulting sold 568 ARK Genomic Revolution ETF shares in Q2 2025, an estimated $11.8K.
  • Carolinas Wealth Consulting first reported a position in ARK Genomic Revolution ETF in Q1 2020 and held it in 21 quarters.
  • Carolinas Wealth Consulting's ARK Genomic Revolution ETF position peaked at $1.27M in Q4 2020.
  • 213 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2025.

Based on Carolinas Wealth Consulting's 13F filing for Q2 2025.